Lab Presentations

Dynamic ion transport gene expression in mouse brain following oxygen and glucose deprivation (OGD). Novak, A.E., Elliott, J.P. Presented at the Society for Neuroscience Annual Meeting, Washington, D.C. Nov. 15-19, 2008.

The neuroprotective role of astrocytes against oxygen glucose deprivation in mouse hippocampal cultures. Jones, S.M., Novak, A.E, Elliott, J.P. Presented at the Society for Neuroscience Annual Meeting, Chicago, IL, Oct. 17-21, 2009.

Preconditioning with low doses of cobalt chloride protects cultured neurons against ischemic insult. S. M. JONES, A. E. NOVAK, P. ELLIOTT. Presented at the Society for Neuroscience Annual Meeting, Washington D.C., Nov. 12-16, 2011.

Induction of the hypoxic pathway in mouse hippocampal organotypic cultures using the hypoxic- mimetic, cobalt chloride.  Novak, A.E., Jones, S.M., Elliott, J.P. Presented at the Society for Neuroscience Annual Meeting, Washington D.C., Nov. 12-16, 2011.

PUB1 Differential temporal expression of HIF targets may underlie neuroprotection versus toxicity. S. M. JONES, A. E. NOVAK, P. ELLIOTT. Presented at the Society for Neuroscience Annual Meeting, New Orleans, LA, Oct. 13-17, 2012.

Differential regulation of target genes of HIF in mouse hippocampal cultures. Novak, A.E., Jones, S.M., Elliott, J.P. Presented at the Society for Neuroscience Annual Meeting, New Orleans, LA, Oct. 13-17, 2012.

 Methamphetamine induces activation of eNOS in cultured mouse brain endothelial cells. J. W. SEO, S. M. JONES, J. P. ELLIOTT, G. A. WEST. Presented at the Society for Neuroscience Annual Meeting, Washington, D.C. Nov. 15-19, 2014.

IV treatment with arginine-vasopressin receptor blocker Vaprisol reduces ischemia-evoked brain edema and blood-brain barrier disruption. Emil Zeynalov MD, Susan M. Jones PhD, Jeong-Woo Seo MS, J. Paul Elliott MD. Presented at the Critical Care Congress of The Society for Critical Care Medicine, Phoenix, AZ, Jan. 17-21, 2015.

The arginine-vasopressin receptor blocker Conivaptan reduces stroke-evoked brain edema and blood-brain-barrier disruption. S. M. Jones, E. Zeynalov, J. Seo, L. Snell, J. P. Elliott. Presented at the Society for Neuroscience Annual Meeting, Chicago, IL, Oct. 17-21, 2015.PUB2

A pre-clinical study of the effects of arginine-vasopressin receptor blockers conivaptan and tolvaptan on stroke-evoked brain edema. Emil Zeynalov MD, Susan M. Jones PhD, Jeong-Woo Seo MS, Lawrence D. Snell, J. Paul Elliott MD. Presented at the Rocky Mountain Neurosurgical Society Annual Meeting, Colorado Springs, CO, June 20-24, 2015.

Therapeutic Time Window for Conivaptan Treatment of Cerebral Edema and Blood-Brain Barrier Breakdown in Mice. Emil Zeynalov MD, Susan M. Jones PhD, J. Paul Elliott MD. Presented at the International Stroke Conference, Los Angeles, CA, Feb. 17-19, 2016.